| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3948235 | Gynecologic Oncology Reports | 2015 | 4 Pages |
Abstract
•We present two cases of advanced uterine cancer that were treated with the combination of metronomic cyclophosphamide and bevacizumab.•Targeting angiogenesis can provide disease control in patients with advanced uterine cancer.•Randomized controlled trials comparing metronomic and conventional regimens in advanced uterine cancer are required.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ioannis Alagkiozidis, Melissa Lozano, Mithun Devraj, Yi-Chun Lee, Ovadia Abulafia,